Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 8 results.
User Information
Export Records
  1. 1.   Near-infrared duocarmycin photorelease from a Treg-targeted antibody-drug conjugate improves efficacy of PD-1 blockade in syngeneic murine tumor models
  2. Fukushima, Hiroshi; Furusawa, Aki; Takao, Seiichiro; Thankarajan Mini Mablet,Ebaston; Luciano, Michael P; Usama, Syed Muhammad; Kano, Makoto; Okuyama, Shuhei; Yamamoto, Hiroshi; Suzuki, Motofumi; Kano, Miyu; Choyke, Peter L; Schnermann,Martin; Kobayashi, Hisataka
  3. Oncoimmunology. 2024, Jun 20; 13(1): 2370544.
  1. 2.   Engineering CD276/B7-H3-targeted antibody-drug conjugates with enhanced cancer-eradicating capability
  2. Feng,Yang; Lee,Jaewon; Yang,Liping; Hilton,Mary; Morris,Karen; Seaman,Steven; Edupuganti,Shivaji; Hsu,Kuo-Sheng; Dower, Christopher; Yu,Guojun; So,Daeho; Bajgain,Pradip; Zhu, Zhongyu; Dimitrov, Dimiter S; Patel,Nimit; Robinson,Christina; Difilippantonio,Simone; Dyba,Marzena; Corbel,Amanda; Basuli, Falguni; Swenson, Rolf E; Kalen,Joseph; Suthe, Sreedhar Reddy; Hussain, Myer; Italia, James S; Souders, Colby A; Gao, Ling; Schnermann,Martin; St Croix,Brad
  3. Cell Reports. 2023, Nov 28; 42(12): 113503.
  1. 3.   A HER2 Antibody Drug Conjugate Controls Growth of Breast Cancer Brain Metastases in Hematogenous Xenograft Models, with Heterogeneous Blood-Tumor Barrier Penetration Unlinked to a Passive Marker
  2. Gril, Brunilde; Wei, Debbie; Zimmer, Alexandra S; Robinson,Christina; Khan, Imran; Difilippantonio,Simone; Overstreet, Michael G; Steeg, Patricia S
  3. Neuro-Oncology. 2020, Nov; 22(11): 1625-1636.
  1. 4.   N-terminal alpha-amino group modification of antibodies using a site-selective click chemistry method
  2. Li, De-zhi; Han, Bing-nan; Wei, Rui; Yao, Gui-Yang; Chen, Zhizhen; Liu, Jie; Poon, Terence C. W.; Su, Wu; Zhu, Zhongyu; Dimitrov, Dimiter S.; Zhao, Qi
  3. MABS. 2018, Jul; 10(5): 712-719.
  1. 5.   Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development
  2. Li, Wei; Zhu, Zhongyu; Chen, Weizao; Feng, Yang; Dimitrov, Dimiter S.
  3. Frontiers in Immunology. 2017, Nov 13; 8: 1554.
  1. 6.   Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma
  2. Bosse, Kristopher R; Raman, Pichai; Zhu, Zhongyu; Lane, Maria; Martinez, Daniel; Heitzeneder, Sabine; Rathi, Komal S; Kendsersky, Nathan M; Randall, Michael; Donovan, Laura; Morrissy, Sorana; Sussman, Robyn T; Zhelev, Doncho V; Feng, Yang; Wang, Yanping; Hwang, Jennifer; Lopez, Gonzalo; Harenza, Jo Lynne; Wei, Jun S; Pawel, Bruce; Bhatti, Tricia; Santi, Mariarita; Ganguly, Arupa; Khan, Javed; Marra, Marco A; Taylor, Michael D; Dimitrov, Dimiter; Mackall, Crystal L; Maris, John M
  3. Cancer Cell. 2017, Sep 11; 32(3): 295-309.e12.
  1. 7.   Stable and Potent Selenomab-Drug Conjugates
  2. Li, Xiuling; Nelson, Christopher; Nair, Rajesh R; Hazlehurst, Lori; Moroni, Tina; Martinez-Acedo, Pablo; Nanna, Alex R; Hymel, David; Burke, Terrence; Rader, Christoph
  3. Cell Chemical Biology. 2017, Apr 20; 24(4): 433-442.
  1. 8.   A near-infrared light-mediated cleavable linker strategy using the heptamethine cyanine chromophore
  2. Luciano,Michael; Nourian, Saghar; Gorka, Alexander P; Nani, Roger R; Nagaya, Tadanobu; Kobayashi, Hisataka; Schnermann,Martin
  3. Methods in enzymology. 2020 641: 245-275.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel